Bharat Biosense develops integrated biotechnology and artificial intelligence platforms for sustainability, molecular science and precision medicine.
Bharat Biosense Private Limited is a deep-technology life sciences company at the nexus of biotechnology, artificial intelligence, and molecular science.
Founded with a mission to build India's indigenous capability in advanced life sciences, we engineer solutions that span the full continuum — from computational drug discovery and stable isotope production to algal biotechnology and precision diagnostics.
Our platforms are designed to serve pharmaceutical companies, research institutions, hospitals, and government bodies — delivering scientific rigour, regulatory confidence, and transformative outcomes at global standards.
Each vertical is a self-sustaining science platform — engineered for depth, designed for scale, united by a single data and intelligence layer.
Deploying transformer-based large biological models, generative AI, and physics-informed neural networks for de novo drug design, protein structure prediction, and multi-omics data integration.
Built on rigorous scientific research, our integrated production platform transforms stable isotopes into high-purity research compounds through precision bioprocessing, analytical validation, and scalable manufacturing.
Nature-science products for homes, offices and commercial spaces — harnessing algal biotechnology and plant intelligence to create clean air, sustainable wellness, and eco-smart environments.
From target identification to experimentally validated hits — our integrated AI and biophysical pipeline compresses drug discovery timelines from years to months.
3D homology modelling & active site identification from sequence to structure.
Binding affinity ranking via transformer-based AI models across millions of compounds.
Inhibitors docked against validated targets to produce top-ranked binding complexes.
High-rank complexes subjected to molecular dynamics for thermodynamic stability assessment.
Protein synthesis, binding assays, ADMET prediction and preclinical development support.
Living products powered by algal biotechnology and botanical science — bringing nature's intelligence to homes, offices, schools and commercial environments.
OxyAasn photobioreactors cultivate living microalgae within sleek, purpose-built enclosures. The algae continuously absorb CO₂ and emit fresh oxygen through photosynthesis, turning any room into a self-sustaining microenvironment. Designed for Homes, Offices, Schools and Public Spaces.
A unified platform architecture where AI accelerates biology, biology validates models, and molecular science provides the measurable ground truth.
Transformer models, graph neural networks & generative AI trained on biological data
Genomics, proteomics, cell biology & metabolomics integrated into a unified biological intelligence layer
Stable isotopes, NMR spectroscopy, structural biology & mass spectrometry grounding every insight in physical reality
Three core technology platforms driving our research, product development, and collaborative innovation programs.
Generative molecular design and multi-parameter optimisation using physics-aware deep learning architectures. Reduce discovery timelines from years to months.
Algae-based biosynthesis of ¹³C-labelled compounds for NMR spectroscopy, metabolic flux analysis, and pharmaceutical tracer development.
High-density photobioreactor cultivation, strain optimisation via adaptive laboratory evolution, and scalable downstream processing of microalgal biomass.
Precision diagnostics, isotope-based imaging, and AI-driven clinical decision support for modern hospitals and health systems.
Isotope-labelled reagents, AI-augmented literature analysis, and collaborative R&D programs for leading research organisations.
Enabling cutting-edge university research through reagent supply, computational access, and joint research programs.
Four defining attributes that distinguish us from every other life sciences company in the country — and most in the world.
Every product and platform emerges from rigorous peer-reviewed science. We publish openly, collaborate widely, and build IP that lasts decades — not quarters.
Our AI, biology, and molecular science layers communicate continuously — meaning predictions get validated experimentally, and experiments inform better models in a closed loop.
India's first integrated stable isotope and AI drug discovery platform — reducing dependence on imports, building sovereign capability, and generating high-value exports.
Photosynthesis-driven production routes, circular bioeconomy principles, and life-cycle-optimised manufacturing — delivering science without compromising the planet.
Whether you're a pharmaceutical company seeking an AI drug discovery partner, a research institute in need of stable isotopes, or an investor looking at the next frontier of life sciences — we'd like to hear from you.